Abstract
Anesthetic Management of a Patient with Von Willebrand Disease This case report describes an anesthesia-related adverse event encountered in the hospital operating room with regards to profuse esophageal bleeding intra operatively and post operatively in a patient with Von Willebrand disease (VWD) Type 1. Although Type 1 typically does not cause profuse bleeding, anesthesia providers should have a high suspicion of bleeding involving any procedures in the oropharynx such as TEE or EGD. Discussed are the anesthetic considerations of drawing baseline labs, assess the risk of bleeding, pretreat DDAVP and anticipate second line treatments. Have Humate-P available on site in case the bleeding is uncontrolled. Second line treatments include cryoprecipitate and tranexemic acid.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
